Aduhelm: Biogen abandons Alzheimer’s drug after controversial approval left it unfunded by Medicare

Authors: Owen Dyer

Published: 2024-02-02

DOI: 10.1136/bmj.q281

Source: Full article

Abstract

No abstract found.